Molecular Templates to Present at the BioCentury 24th Annual Newsmakers in the Biotech Industry Conference

AUSTIN, Texas, Sept. 06, 2017 -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that Eric E. Poma, Ph.D., Chief Executive and Chief Scientific Officer, will provide a corporate overview at the BioCentury 24^th Annual Newsmakers in the Biotech Industry conference, being held September 8th at the Millennium Broadway Hotel in New York City.

Presentation Details:
Date:               Friday, September 8
Time:               2:00pm Eastern Time
Location:         The Millennium Broadway Hotel, Presentation Room 311
Webcast:         http://www.wsw.com/webcast/biocentury4/mtem/index.aspx

About Molecular Templates 
Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases.  For additional information, please visit Molecular Templates’ website at ​www.mtem.com.

Investor Contact:
Andrew McDonald, Ph.D.
[email protected]
646-597-6987